Covid-19 – Neuroperforma is now open. In order to keep everyone safe, our staff and customers will now wear a mask. Our trainers wear a visor when installing the cap. Plexiglass have been installed in several places. The rooms and common areas are disinfected between each session and clients with symptoms, who have been in contact with a symptomatic person or who have traveled outside Canada in the past two weeks will not be admitted. These measures have been put in place to serve you safely!
Difficulties encountered which could be enhanced
Although no treatment is yet available to cure Alzheimer’s disease, several studies have shown that Neurofeedback can lead to improvements at different levels including working memory, cognitive processes, executive functions and sleep1. The studies carried out are still few, but the results obtained so far present a wave of encouragement.
Different regions of the brain are usually affected in Dementia or Alzheimer’s.
First, an infringement in the temporal lobes (located above the ears) and the hippocampus (located more in the center of the brain) will cause difficulties in memory and learning.
Then, a dysfunction of the frontal lobes will bring difficulties in the planning, the organization, as well as at the level of the judgment.
Finally, when the parietal lobes (located on the upper back of the head) do not work properly, difficulties of understanding and logic can appear. Then it will be more difficult to follow the discussions and to express themselves clearly by using an appropriate vocabulary.
With Neurofeedback, we aim to stimulate the temporal regions (above the ears) as well as certain deep regions on each side that are involved in the memory such as the hippocampus and the cingulate gyrus.
- Functional improvement
- Better autonomy
- Improved memory
- Improvement of the quality of life
- Increased cognitive awakening
As previously mentioned, the approach used by Neuroperforma will not treat Alzheimer’s disease. However, as shown in the graphs below from the reference article, we can observe improvements in the Mini Mental State Examination (MMSE) scores, both in individuals with Alzheimer’s disease (AD) and those with vascular dementia (DV)
Knowing the necessary involvement of loved ones to bring individuals regularly in our clinics to do their training sessions, Neuroperforma now offers to go do the evaluations and training directly in residences. A minimum of registration is required as well as the collaboration of the institution to carry out these projects. Contact us for more information.
Here is a case from the Neuroperforma Clinic. In an Alzheimer’s test called MoCA, the neuropsychologist asks the individual to draw a clock with a specific time. We can notice a noticeable improvement between the test done at the beginning of the process and the one done after several training of Neurofeedback.
1. Clinical EEG and Neuroscience 2015
Quantitative EEG Neurometric Analysis Guided Neurofeedback Treatment in
Dementia: 20 Cases. How is Neurometric Analysis Important for the Treatment of
Dementia and a Biomarker?
See the article